Orbimed Advisors - VERVE THERAPEUTICS INC ownership

VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 69 filers reported holding VERVE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of VERVE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$6,025,000100,0000.06%
Other shareholders
VERVE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,508,809$57,251,0008.18%
Alphabet Inc. 10,974,011$250,427,0008.12%
M28 Capital Management LP 178,500$4,073,0003.74%
Casdin Capital, LLC 3,138,167$71,613,0003.21%
Ally Bridge Group (NY) LLC 105,360$2,404,0001.78%
Redmile Group, LLC 1,835,328$41,882,0001.31%
Cormorant Asset Management, LP 700,710$15,990,0001.23%
Novo Holdings A/S 750,000$17,115,0000.90%
Artal Group S.A. 400,000$9,128,0000.38%
PFM Health Sciences, LP 369,765$8,438,0000.32%
View complete list of VERVE THERAPEUTICS INC shareholders